| Presentation Title |
Presenter |
| CPSS Guidelines and Standards |
Dr. Morris Markentin |
| What is Substance Use Disorder? |
Dr. Peter Butt |
| Opioid Substitution Therapy: Weighing the Risks & Benefits Disclosure |
Dr. Leo Lanoie |
| Professionalism |
Brenda Senger |
| The Importance of the Team Approach |
Dr. Larissa Pawluck
|
| Who is Suitable for Opoid Substitution Therapy? |
Courtney Morin |
| Patient Assessment |
Dr. Morris Markentin
|
| Dosing |
Dr. Morris Markentin |
| Urine Drug Screening to Optimize Treatment |
Dr. Larissa Pawluck
|
| The Role of Carries in Treatment |
Dr. Morris Markentin
|
| The Role of the Pharmacist |
Kirsty Carlson
|
| Fentanyl |
Dr. Peter Butt
|
| Take-Home Naloxone Kits |
Dr. Peter Butt |
| Recovery Streams |
Ruth White
|
| Ahtahkakoop Cree Nation |
Dr. David Crawford/
Tanya Hounsell |
| Discharge: When is it Appropriate? |
Dr. Peter Butt
|
| Mental Health & Addiction Care (Parts 1 & 2) |
Dr. Stefan Brennan |
| Managing Co-Morbidities: Hep C, HIV, COPD |
Dr. Morris Markentin
|
| Managing Concurrent Pain & Addiction |
Dr. Leo Lanoie
|
| Opioid Substitution Therapy and Pregnancy |
Dr. George Carson
|
|
|
| Saskatchewan Opioid Substitution Therapy Guidelines and Standards |
|